Ved Bhushan Arya1, Garima Chawla2, Aparna K R Nambisan2, Nadia Muhi-Iddin3, Ekaterini Vamvakiti4, Michal Ajzensztejn5, Tony Hulse5, Clare Ferreira Pinto6, Nayana Lahiri7, Susan Bint8, Charles R Buchanan2, Ritika R Kapoor2. 1. Department of Paediatric Endocrinology, King's College Hospital NHS Foundation Trust, London, United Kingdom, vedarya@nhs.net. 2. Department of Paediatric Endocrinology, King's College Hospital NHS Foundation Trust, London, United Kingdom. 3. Department of Paediatrics, East Sussex Healthcare NHS Trust, Eastbourne, United Kingdom. 4. Department of Paediatrics, Western Sussex Hospitals NHS Foundation Trust, Worthing, United Kingdom. 5. Department of Paediatric Endocrinology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom. 6. South West Thames Regional Genetics Laboratory, St George's University Hospitals NHS Foundation Trust, London, United Kingdom. 7. Clinical Genetics Department, St George's University Hospitals NHS Foundation Trust, London, United Kingdom. 8. Viapath Genetics Laboratories, Guy's Hospital, London, United Kingdom.
Abstract
BACKGROUND: Xq27.1 duplication encompassing SOX3 has been implicated in the aetiology of X-linked hypopituitarism associated with intellectual disability and neural tube defects. We describe the largest case series to date of 5 unrelated patients with SOX3 duplication with a variable clinical phenotype, including the smallest reported SOX3 duplication. CASE REPORTS: Five male patients who presented with congenital hypopituitarism (CH) were identified to have Xq27.1 duplication encompassing SOX3. The size of the duplication ranged from 323.8 kb to 11 Mb. The duplication was maternally inherited or de novo in 2 patients each (and of unknown inheritance in 1 patient). The age at presentation was variable. Three patients had multiple pituitary hormone deficiencies, whereas 2 patients had isolated growth hormone deficiency. All patients had micropenis and/or small undescended testes. Structural pituitary and/or other midline cranial abnormalities (callosal hypogenesis/absence of the septum pellucidum) were present in all patients. Two patients had a neural tube defect in addition to CH. CONCLUSIONS: This is the largest series reported to date of unrelated patients with CH in association with Xq27.1 duplication encompassing SOX3. The clinical phenotype is variable, which may be due to genetic redundancy or other unknown aetiological factors. We have expanded the phenotypic spectrum through description of the smallest Xq27.1 duplication (323.8 kb) with CH reported to date, as well as a second family with CH and a neural tube defect.
BACKGROUND: Xq27.1 duplication encompassing SOX3 has been implicated in the aetiology of X-linked hypopituitarism associated with intellectual disability and neural tube defects. We describe the largest case series to date of 5 unrelated patients with SOX3 duplication with a variable clinical phenotype, including the smallest reported SOX3 duplication. CASE REPORTS: Five male patients who presented with congenital hypopituitarism (CH) were identified to have Xq27.1 duplication encompassing SOX3. The size of the duplication ranged from 323.8 kb to 11 Mb. The duplication was maternally inherited or de novo in 2 patients each (and of unknown inheritance in 1 patient). The age at presentation was variable. Three patients had multiple pituitary hormone deficiencies, whereas 2 patients had isolated growth hormone deficiency. All patients had micropenis and/or small undescended testes. Structural pituitary and/or other midline cranial abnormalities (callosal hypogenesis/absence of the septum pellucidum) were present in all patients. Two patients had a neural tube defect in addition to CH. CONCLUSIONS: This is the largest series reported to date of unrelated patients with CH in association with Xq27.1 duplication encompassing SOX3. The clinical phenotype is variable, which may be due to genetic redundancy or other unknown aetiological factors. We have expanded the phenotypic spectrum through description of the smallest Xq27.1 duplication (323.8 kb) with CH reported to date, as well as a second family with CH and a neural tube defect.
Authors: Melitza S M Elizabeth; Annemieke J M H Verkerk; Anita C S Hokken-Koelega; Joost A M Verlouw; Jesús Argente; Roland Pfaeffle; Sebastian J C M M Neggers; Jenny A Visser; Laura C G de Graaff Journal: Pituitary Date: 2020-11-13 Impact factor: 4.107
Authors: Caiqi Du; Feiya Wang; Zhuoguang Li; Mini Zhang; Xiao Yu; Yan Liang; Xiaoping Luo Journal: BMC Med Genomics Date: 2022-02-03 Impact factor: 3.063